Provided by Tiger Trade Technology Pte. Ltd.

Quest Diagnostics

233.07
+1.100.47%
Volume:1.09M
Turnover:255.91M
Market Cap:25.72B
PE:24.75
High:236.97
Open:233.33
Low:230.84
Close:231.97
52wk High:248.84
52wk Low:171.18
Shares:110.37M
Float Shares:110.00M
Volume Ratio:1.02
T/O Rate:0.99%
Dividend:3.32
Dividend Rate:1.42%
EPS(TTM):9.42
EPS(LYR):8.75
ROE:14.60%
ROA:6.40%
PB:3.42
PE(LYR):26.64

Loading ...

Quest Diagnostics Inc. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Jul 07

Quest Diagnostics (DGX) Could Be 4% Undervalued On Haystack MRD Approval

Simply Wall St.
·
Jul 06

How Investors Are Reacting To Quest Diagnostics (DGX) New MRD Test Milestone And Attunio Partnership

Simply Wall St.
·
Jul 04

Quest Diagnostics Inc. Stock Underperforms Wednesday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 02

Quest Diagnostics Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jun 30

Quest Diagnostics Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jun 26

Quest Diagnostics’ Haystack MRD test receives New York SDOH approval

TIPRANKS
·
Jun 24

Quest Diagnostics Receives New York State Approval for Haystack Mrd®, Broadening Patient Access to Ctdna Minimal Residual Disease Testing

THOMSON REUTERS
·
Jun 24

Quest Wins New York State Approval for Haystack MRD Ctdna Test

Reuters
·
Jun 24

Quest Diagnostics Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Jun 24

Quest Diagnostics (DGX) Stock Could Be 12.7% Below Fair Value on Testing Growth Narrative

Simply Wall St.
·
Jun 21

Quest Diagnostics Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
Jun 19

Health Rounds: Experimental first-in-class heart drug may also help heal kidneys

Reuters
·
Jun 19

Quest study finds 69.5% of multidrug-resistant Klebsiella pneumoniae non-susceptible to top oral UTI antibiotics

Reuters
·
Jun 18

Quest Diagnostics Inc. Stock Outperforms Competitors Despite Losses On The Day

Dow Jones
·
Jun 18

Quest Diagnostics to report Q2 results, host earnings call

Reuters
·
Jun 17

Quest Diagnostics releases 2025 Corporate Responsibility Report

Reuters
·
Jun 16

GeneDx names former Quest executive Mark Gardner as president

Reuters
·
Jun 16

Quest Diagnostics highlights 2025 corporate responsibility progress, testing reach and sustainability gains

Reuters
·
Jun 16

Quest Diagnostics Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Jun 09